- Home
- MNPR vs IBEX Comparison
MNPR vs IBEX Comparison
Compare MNPR & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- IBEX
- Stock Information
- Founded
- MNPR 2014
- IBEX 2017
- Country
- MNPR United States
- IBEX United States
- Employees
- MNPR N/A
- IBEX N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- IBEX EDP Services
- Sector
- MNPR Health Care
- IBEX Technology
- Exchange
- MNPR Nasdaq
- IBEX Nasdaq
- Market Cap
- MNPR 390.5M
- IBEX 386.9M
- IPO Year
- MNPR 2019
- IBEX 2020
- Fundamental
- Price
- MNPR $86.16
- IBEX $37.37
- Analyst Decision
- MNPR Strong Buy
- IBEX Hold
- Analyst Count
- MNPR 12
- IBEX 3
- Target Price
- MNPR $96.64
- IBEX $31.00
- AVG Volume (30 Days)
- MNPR 97.3K
- IBEX 103.3K
- Earning Date
- MNPR 11-10-2025
- IBEX 11-06-2025
- Dividend Yield
- MNPR N/A
- IBEX N/A
- EPS Growth
- MNPR N/A
- IBEX 28.02
- EPS
- MNPR N/A
- IBEX 2.36
- Revenue
- MNPR N/A
- IBEX $558,273,000.00
- Revenue This Year
- MNPR N/A
- IBEX $10.15
- Revenue Next Year
- MNPR N/A
- IBEX $5.82
- P/E Ratio
- MNPR N/A
- IBEX $15.86
- Revenue Growth
- MNPR N/A
- IBEX 9.77
- 52 Week Low
- MNPR $12.55
- IBEX $17.53
- 52 Week High
- MNPR $105.00
- IBEX $42.99
- Technical
- Relative Strength Index (RSI)
- MNPR 57.75
- IBEX 50.82
- Support Level
- MNPR $77.00
- IBEX $36.69
- Resistance Level
- MNPR $89.32
- IBEX $38.02
- Average True Range (ATR)
- MNPR 7.00
- IBEX 0.82
- MACD
- MNPR -1.45
- IBEX -0.09
- Stochastic Oscillator
- MNPR 44.25
- IBEX 53.30
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.